BRIEF published on 11/14/2024 at 15:31, 1 year 4 months ago Novacyt launches new veterinary tests Gastrointestinal Diseases Novacyt Molecular Diagnosis Veterinary Tests Pathogens
BRIEF published on 11/01/2024 at 14:00, 1 year 4 months ago Novacyt: Update on liquidity contract and voting rights Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 11/01/2024 at 13:57, 1 year 4 months ago Novacyt Updates on Liquidity Agreement and Voting Rights Liquidity Agreement INVEST SECURITIES Total Voting Rights French Law Novacyt Shares
PRESS RELEASE published on 11/01/2024 at 13:52, 1 year 4 months ago Liquidity Agreement and Total Voting Rights Novacyt provides liquidity agreement update and total voting rights information, with Invest Securities purchasing and selling ordinary shares. Company divided into clinical, instrumentation, and research use segments Ordinary Shares Liquidity Agreement Total Voting Rights Novacyt Clinical Diagnostics
BRIEF published on 10/31/2024 at 10:28, 1 year 4 months ago Dr. Ian Gilham Joins Novacyt as Non-Executive Director Life Sciences Board Appointment Non-Executive Director Novacyt Dr. Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 1 year 4 months ago Appointment of Dr Ian Gilham to the Board of Directors of Novacyt Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE published on 10/31/2024 at 10:23, 1 year 4 months ago Directorate Change Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed
BRIEF published on 10/17/2024 at 11:47, 1 year 5 months ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
BRIEF published on 10/10/2024 at 12:28, 1 year 5 months ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
BRIEF published on 10/10/2024 at 12:27, 1 year 5 months ago Novacyt Closes IT-IS International Subsidiary Amid Market Saturation Financial Impact Intellectual Property Novacyt PCR Market IT-IS Closure
Published on 03/26/2026 at 04:55, 3 hours 19 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 7 hours 34 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 7 hours 44 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 12 hours 59 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 08:00, 13 minutes ago PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 14 minutes ago Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 14 minutes ago CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 08:00, 14 minutes ago LPKF reports slight improvement in earnings in 2025 and initiates Group realignment
Published on 03/26/2026 at 07:30, 44 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 13 hours 43 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 14 hours 29 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
